NCT07511920Not yet recruiting
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
A Real-World, Multicenter Cohort Study on the Natural History of Duchenne and Becker Muscular Dystrophy in Children From Western China
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
This is a prospective, multicenter, longitudinal observational cohort study aimed at understanding the progression of Duchenne Muscular Dystrophy (DMD). The primary objective is to identify and integrate key biomarkers from multiple sources-including motor function assessments, body composition (muscle and fat distribution), clinical laboratory tests, and cardiopulmonary imaging-to delineate comprehensive disease trajectories. By analyzing how these factors change over time in a large cohort, the study seeks to develop a robust model that can identify patterns of disease progression. The ultimate goal is to generate evidence that may aid in forecasting individual patient outcomes and inform the future development of personalized rehabilitation and therapeutic strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 30 Mar 2026
- Start date
- 20 Apr 2026
- Primary completion date
- 30 Dec 2028
- Lead sponsor
- West China Second University Hospital
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT07511920
What you commit to
- Study type: Observational
- Planned participants: 500
- From 20 Apr 2026 to the primary completion date, 30 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with other neuromuscular disorders that may confound natural history data
- Participation in another interventional clinical trial that could affect disease progression
Other
- Severe comorbidities that prevent completion of study assessments
- Inability to provide informed consent or comply with study procedures
Who the study is looking for
- Male participants with genetically confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (BMD)
- Age range: 1 to 18 years old (adjust to your actual age limit)
- Ability to complete study assessments and follow-up visits
- Participants or legal guardians provide written informed consent
Age in the registry: 1 year to 18 years · Sex: Male
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| West China Second University Hospital, Sichuan University Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.